# Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis

> **NCT00291915** · PHASE4 · UNKNOWN · sponsor: **Goupe d'Etudes et de Recherche Clinique En Rhumatologie** · enrollment: 80 (—)

## Conditions studied

- Rheumatoid Arthritis
- Arthritis

## Interventions

- **DRUG:** Adalimumab
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00291915
- **Lead sponsor:** Goupe d'Etudes et de Recherche Clinique En Rhumatologie
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 80 (—)
- **Last updated:** 2006-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291915, "Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00291915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*